Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

www.cefalea.it: the first five years.

Paolo Rossi1, Grazia Sances, Giuseppe Nappi

  • 1Headache Clinic, INI Grottaferrata, Via S. Anna, snc,, I-00046, Rome, Italy. paolo.rossi90@aliceposta.it

The Journal of Headache and Pain
|December 20, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort.

Cephalalgia : an international journal of headache·2026
Same author

Beyond Pain: Psychological Profiles in Chronic Migraine Compared With Fibromyalgia and Their Comorbidity.

Annals of the New York Academy of Sciences·2026
Same author

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Neurology·2026
Same author

Translation and validation of the Migraine Interictal Burden Scale (MIBS-4) in an Italian clinical cohort.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same author

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Neurology·2026
Same author

miR-382-5p and miR-34a in migraine: Expression in monocytes and a post-hoc exploratory comparison with expression in peripheral blood mononuclear cells.

Cephalalgia : an international journal of headache·2025

The Italian headache disorders website (www.cefalea.it) has seen significant growth since 1999. It demonstrates the internet's potential to enhance headache patient education and support.

Area of Science:

  • Neurology
  • Digital Health
  • Patient Advocacy

Background:

  • The Italian headache disorders website (www.cefalea.it) was established in 1999.
  • It is a collaboration between the CIRNA foundation and Al.Ce, a patient association.
  • The website is affiliated with the World Headache Alliance.

Purpose of the Study:

  • To summarize the first five years of the website's activity.
  • To highlight the potential of the internet in managing headache disorders.
  • To assess the impact on patient decision-making, behavior, and outcomes.

Main Methods:

  • Analysis of website traffic and user engagement data from 1999 to 2004.
  • Identification of the most frequently accessed sections.
  • Review of the website's content and resources.

Related Experiment Videos

Main Results:

  • Website traffic increased by over 200% from 1999 to 2004, reaching nearly 130,000 hits in 2004.
  • Popular sections included topical information, a specialist directory, a glossary, and a support group.
  • The website serves as a valuable resource for headache information and support.

Conclusions:

  • The website has demonstrated significant growth and user engagement.
  • The internet is a powerful tool for improving headache disorder management.
  • Online resources can positively influence patient knowledge and self-care.